Beaconcure Overview
Beaconcure has developed an automated solution, supported by machine learning, for clinical data validation. The technology was designed to support regulatory submissions in drug and vaccine development. The company developed Verify, an automated SaaS system using machine learning and natural language processing to manage clinical trial output data. The system automates the validation of statistical analysis clinical outputs. Developed specifically for the needs of clinical trial quality assurance, Verify allows users to bring a production-ready product to market faster, without compromising quality.
Cumulative Funding Raised Over Time ($)
$1.2MMar 2018
$15.2MMar 2023
$17.2MNov 2021
Latest News
growth-positive
להאיץ ולדייק את המחקרים: Beaconcure משפרת את פיתוח...
Beaconcure Technologies, an Israeli startup, is working to automate the process of organizing data from clinical trials of new drugs, a process that is currently done manually and often results in delays, errors, and high costs. The company has developed an automation tool that identifies problematic areas in the data, saving up to six weeks of work. Beaconcure has raised a total of $20 million in equity and an additional $650,000 grant from the Innovation Authority. The company has five major clients, including Pfizer, Ono Pharmaceutical, and CSL.
InvestmentCustomersExpand
Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform
growth-positive
Clinical trial data company Beaconcure eyes US expansion
Beaconcure, a clinical trial data analysis provider, is planning to expand its global footprint by relocating its CEO to Boston in August. The companys platform, Verify, is designed to review clinical trial datasets and identify inconsistencies and errors. Beaconcure initially focused on validating medical research but pivoted towards validating clinical trial data output in partnership with Pfizer. The platform was used to validate data from Pfizers Covid-19 vaccine clinical trials. Beaconcures expansion is aimed at improving its commercial coverage in the US. The company recognizes the need for digitization in the clinical trial space to reduce regulatory delays and ensure data accuracy.
Expand
growth-positive
Beaconcure Announces Webinar Series on How Automation Can Play a Key Part in Accelerating Drug Approval
Beaconcure, a company that developed an ML/NLP-driven analytics platform for the life science industry, is hosting a webinar on how automation can accelerate drug delivery approval. The webinar will address the challenges in validating clinical trial data, the AI solution developed with Pfizer, the business opportunity, and future trends in clinical programming practices. The webinar will feature speakers from Pfizer, Parexel, Takeda, Beaconcure, and will take place on October 5, 2021. Beaconcures technology helps pharmaceutical companies and CROs improve the quality of their outputs by identifying programming issues, specification deficiencies, and data inconsistencies. Their solution converts tabular outputs into a structured database, reducing processing timelines and increasing the quality of deliverables.
CustomersPartners
growth-positive
החברה הישראלית שעשויה לקצר את הדרך לחיסון
Israeli company Beaconcure, which has developed algorithms for the autonomous analysis of scientific papers, is expected to collaborate with a leading company in the development of vaccines for COVID-19 to further shorten the development process. Beaconcures technology allows drug development companies to review the results of the experiment submitted to regulatory bodies such as the FDA to ensure there are no errors or inconsistencies in the data or text. This can save a significant part of the back and forth process that may last weeks or even months.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $17.9M |
| Last funding | $14M |
| Stage | B |
| Rounds | 4 |
| Investors | 3 |
Team Members
8
Employees: 11-50
Web & Social Links
| Website | beaconcure.com |
Locations
Bialik St 147, Ramat Gan, Israel
117 Kendrick St, Needham, MA 02494, USA
Photos & Videos
3 item(s)
Beaconcure Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcareClinical WorkflowTarget Customer
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticalsEducationHigher EducationFinancial ServicesFinancial ProductsInsuranceCore Technology
Artificial IntelligenceMachine LearningNatural Language ProcessingPlatforms & InterfacesSoftwareTags (17)
clinical-trialspharmaceuticalsregulationnatural-language-processinghospitalshealthcare-providersinsurance-companiespharma-companiesmachine-learningacademiadata-analyticsartificial-intelligencedigital-healthcaredecision-supportalgorithmssoftware-developmentcloud-basedGeographic Markets
United StatesEuropeIsraelBeaconcure Financials
$17.9M
Total funding
Undisclosed
Capital raised
$14M
Last funding
B
Funding stage
4
Total rounds
3
Investors
Cumulative Funding Raised Over Time ($)
$1.2MMar 2018
$15.2MMar 2023
$17.2MNov 2021
Private Equity Funding
B Round
Mar 2023
$14M
NewVale Capital (Lead)
A Round
Nov 2021
$2M
Seed
Mar 2018
$1.2M
Random Forest VC (Lead)
,
Noam Stern
Non-Equity Funding
GrantEvent
Jan 2018
$700K
Israel Innovation Authority (Lead)
Beaconcure Lifecycle
Cumulative Funding Raised Over Time
$1.2MMar 2018
$15.2MMar 2023
$17.2MNov 2021
All Events
B Round
Mar 2023
$14M
NewVale Capital (Lead)
A Round
Nov 2021
$2M
Seed
Mar 2018
$1.2M
Random Forest VC (Lead)
,
Noam Stern
GrantEvent
Jan 2018
$700K
Israel Innovation Authority (Lead)
Beaconcure News
6 articles
growth-positive
להאיץ ולדייק את המחקרים: Beaconcure משפרת את פיתוח...
Beaconcure Technologies, an Israeli startup, is working to automate the process of organizing data from clinical trials of new drugs, a process that is currently done manually and often results in delays, errors, and high costs. The company has developed an automation tool that identifies problematic areas in the data, saving up to six weeks of work. Beaconcure has raised a total of $20 million in equity and an additional $650,000 grant from the Innovation Authority. The company has five major clients, including Pfizer, Ono Pharmaceutical, and CSL.
InvestmentCustomersExpand
Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform
growth-positive
Clinical trial data company Beaconcure eyes US expansion
Beaconcure, a clinical trial data analysis provider, is planning to expand its global footprint by relocating its CEO to Boston in August. The companys platform, Verify, is designed to review clinical trial datasets and identify inconsistencies and errors. Beaconcure initially focused on validating medical research but pivoted towards validating clinical trial data output in partnership with Pfizer. The platform was used to validate data from Pfizers Covid-19 vaccine clinical trials. Beaconcures expansion is aimed at improving its commercial coverage in the US. The company recognizes the need for digitization in the clinical trial space to reduce regulatory delays and ensure data accuracy.
Expand
growth-positive
Beaconcure Announces Webinar Series on How Automation Can Play a Key Part in Accelerating Drug Approval
Beaconcure, a company that developed an ML/NLP-driven analytics platform for the life science industry, is hosting a webinar on how automation can accelerate drug delivery approval. The webinar will address the challenges in validating clinical trial data, the AI solution developed with Pfizer, the business opportunity, and future trends in clinical programming practices. The webinar will feature speakers from Pfizer, Parexel, Takeda, Beaconcure, and will take place on October 5, 2021. Beaconcures technology helps pharmaceutical companies and CROs improve the quality of their outputs by identifying programming issues, specification deficiencies, and data inconsistencies. Their solution converts tabular outputs into a structured database, reducing processing timelines and increasing the quality of deliverables.
CustomersPartners
growth-positive
החברה הישראלית שעשויה לקצר את הדרך לחיסון
Israeli company Beaconcure, which has developed algorithms for the autonomous analysis of scientific papers, is expected to collaborate with a leading company in the development of vaccines for COVID-19 to further shorten the development process. Beaconcures technology allows drug development companies to review the results of the experiment submitted to regulatory bodies such as the FDA to ensure there are no errors or inconsistencies in the data or text. This can save a significant part of the back and forth process that may last weeks or even months.
Partners
growth-positive
Researching the researchers
Startup BeaconCure aims to revolutionize the world of higher education by combining information technologies with bioinformatics. The company has developed a search engine that helps researchers find relevant articles and research grant proposals, distinguish between good and bad science, and detect suspicious studies. BeaconCures system also incorporates the wisdom of the crowd and aims to independently generate scientific insights. The company has received investment from Noam Stern-Perry, a shareholder in algorithmic trading company Final. BeaconCure is experiencing positive growth and has run 20 projects with satisfied customers. The company is still in the development process and has not yet decided on its specialization.
InvestmentExpand
Beaconcure Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 39 |
| Team members | 8 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 18 classification IDs that could be used for matching.
Beaconcure Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515339331 |
| Crunchbase | beaconcure |
| Creator | Shmuel (Sam) Rausnitz |
| Creator email | shmuel.rausnitz@sncentral.org |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-07-17T00:00:00.000Z |
| Created | 2016-03-22T00:00:00.000Z |
| Claimed | Yes |